Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA

Deok-Hwa Seo1, Wonhee Hur2, Juhee Won3

  • 1The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Viruses
|January 8, 2025
PubMed

Insights

A new mouse model effectively replicates chronic Hepatitis B virus (HBV) infection, enabling study of HBV cccDNA persistence. This breakthrough aids research into therapies targeting the viral DNA reservoir.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Chronic Hepatitis B virus (HBV) infection poses significant mortality risks due to cirrhosis and hepatocellular carcinoma (HCC).
  • Covalently closed circular DNA (cccDNA) is a persistent viral DNA reservoir in hepatocytes, driving continuous HBV replication and treatment resistance.
  • Existing animal models inadequately replicate cccDNA dynamics, hindering research into HBV pathogenesis and therapeutics.

Purpose of the Study:

  • To develop and validate a novel mouse model for investigating Hepatitis B virus cccDNA formation and maintenance.
  • To establish a platform for evaluating therapeutic strategies targeting the HBV cccDNA reservoir.

Main Methods:

  • Infection of C57BL/6 mice with recombinant adeno-associated virus (rAAV) carrying a 1.3-overlength HBV genome (genotype C).
  • Assessment of cccDNA levels and viral replication markers (HBsAg, HBeAg, HBV DNA) at various time points.
  • Quantitative PCR (qPCR) with selective DNase treatment and Southern blot analysis for cccDNA detection.

Main Results:

  • Successful establishment of a chronic HBV mouse model with persistent cccDNA expression in hepatocytes.
  • Sustained elevation of serum HBsAg and HBeAg for up to 12 weeks with normal alanine transaminase (ALT) levels.
  • Confirmation of HBV DNA expression and detection of cccDNA using qPCR and Southern blot analysis.

Conclusions:

  • The rAAV-HBV1.3 mouse model effectively recapitulates key aspects of chronic HBV infection, including cccDNA persistence.
  • This model serves as a valuable tool for studying long-term cccDNA maintenance and for preclinical testing of novel anti-HBV therapies targeting cccDNA.